Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

GEICAM – Spanish Breast Cancer Group | Researchclopedia

Back to institutions

GEICAM – Spanish Breast Cancer Group

Alcobendasnonprofit

717

Works

67,179

Citations

140

h-index

Top Research Topics

Advanced Breast Cancer Therapies Breast Cancer Treatment Studies HER2/EGFR in Cancer Research

Top Researchers

Alberto Ortíz Universidad de Guanajuato

1,510 works204,019 citationsh-index: 126

Recent Research

ctDNA and tumor-based biomarkers of giredestrant response in acelERA breast cancer

Ann Collier,Stephanie Hilz,et al.

20260 citations

Cancer Treatment and Pharmacology

Cancer Genomics and Diagnostics

Cancer Immunotherapy and Biomarkers

Cancer Risks and Factors

Cancer-related Molecular Pathways

Estrogen and related hormone effects

BRCA gene mutations in cancer

Cancer Cells and Metastasis

Chronic Lymphocytic Leukemia Research

Jörge E. Cortes Augusta University Health

3,571 works143,323 citationsh-index: 179

Carlos Caldas Universidade Federal do Rio de Janeiro

1,380 works128,283 citationsh-index: 158

Jesús F. San Miguel Clinica Universidad de Navarra

2,276 works127,264 citationsh-index: 158

José Baselga Hebron University

1,379 works117,695 citationsh-index: 143

Lorenzo Galluzzi Fox Chase Cancer Center

983 works115,546 citationsh-index: 154

VIKTORIA-1 Trial of Gedatolisib Plus Fulvestrant With or Without Palbociclib in Hormone Receptor–Positive/HER2−/PIK3CA Wild-Type Advanced Breast Cancer

Sara A. Hurvitz,Rachel M. Layman,et al.

20260 citations

Clinical subtypes in breast cancer patients with brain metastases from an ambispective registry of advanced breast cancer, GEICAM/2014-03 (RegistEM)

Sara López-Tarruella,Ángel Guerrero-Zotano,et al.

20260 citations

Abstract RF2-06: Impact of Immune Checkpoint Inhibition (CPI) on Fertility in Young Women with Early Triple-Negative Breast Cancer (TNBC) receiving neoadjuvant Chemotherapy (NACT): A Prospective Substudy of the NSABP B-59/GBG-96-GeparDouze Trial

M. Reinisch,A. Schneeweiss,et al.

20260 citations

Abstract PS3-10-28: Randomized phase II trial evaluating three anti-diarrheal prophylaxis strategies in patients (pts) with HER2+/HR+ early breast cancer (EBC) treated with extended adjuvant neratinib (dianer geicam/2018-06)

Miguel Gil‐Gil,M. Ruiz-Borrego,et al.

20260 citations

Abstract RF3-02: Gene Expression-based Subtyping of Early Triple-Negative Breast Cancer (TNBC) for Prediction of Response to Neoadjuvant Immune-chemotherapy in the NSABP B-59/GBG-96-GeparDouze Trial

C. Denkert,Sivaramakrishna Rachakonda,et al.

20260 citations